Avinoam Shye-Shahar

Avinoam Shye-Shahar

Auto-generated profile, based on publicly available information

Avinoam Shye-Shahar

Department of Ophthalmology, Rambam Health Care Campus, Haifa, Israel

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 March 2022 in PLOS Computational Biology
Verified
Journal Article
Open access
PDF file
DGDavid Groenewoud
David Groenewoud
ASAvinoam Shye
Avinoam Shye
RERan Elkon
Ran Elkon
To date, genome-wide association studies have identified thousands of statistically-significant associations between genetic variants, and phenotypes related to a myriad of traits and diseases. A key goal for human-genetics research is to translate these associations into functional mechanisms. Popular gene-set analysis tools, like MAGMA, map variants to genes they might affect, and then integrate genome-wide association study data (that is, variant-level associations for a phenotype) to score genes for association with a phenotype. Gene scores are subsequently used in competitive gene-set analyses to identify biological processes that are enriched for phenotype association. By default, variants are mapped to genes in their proximity. However, many variants that affect phenotypes are thought to act at regulatory elements, which can be hundreds of kilobases away from their target genes. Thus, we explored the idea of augmenting a proximity-based mapping scheme with publicly-available datasets of regulatory interactions. We used MAGMA to analyze genome-wide association study data for ten different phenotypes, and evaluated the effects of augmentation by comparing numbers, and identities, of genes and gene sets detected as statistically significant between mappings. We detected several pitfalls and confounders of such “augmented analyses”, and introduced ways to control for them. Using these controls, we demonstrated that augmentation with datasets of regulatory interactions only occasionally strengthened the enrichment for phenotype association amongst (biologically-relevant) gene sets for different phenotypes. Still, in such cases, genes and regulatory elements responsible for the improvement could be pinpointed. For instance, using brain regulatory-interactions for augmentation, we were able to implicate two acetylcholine receptor subunits involved in post-synaptic chemical transmission, namely CHRNB2 and CHRNE, in schizophrenia. Collectively, our study presents a critical approach for integrating regulatory interactions into gene-set analyses for genome-wide association study data, by introducing various controls to distinguish genuine results from spurious discoveries. Genome-wide association studies have identified thousands of statistically-significant associations between genetic variants and diverse phenotypes, but translating these associations into functional mechanisms remains a major challenge. Gene-set analyses for genome-wide association study data, which consider the signal contained in practically all variants tested for association with a phenotype, seek functionally-annotated collections of genes that are enriched for phenotype association. To do so, variants must first be mapped to genes they are thought to affect. Usually, variants are mapped to genes in their proximity, even if it is believed that the effects of many variants are, in fact, mediated via long-range regulatory interactions. Here, we demonstrate that augmenting a proximity-based mapping scheme with datasets of regulatory interactions, can strengthen the enrichment for phenotype association amongst gene sets that are biologically-relevant to phenotypes. Yet, by implementing controls, we reveal that apparent improvements are often trivial, or can be explained by confounding. We discuss some examples of meaningful improvements, and pinpoint genes and regulatory elements responsible for them. Incorporating regulatory interactions into gene-set analyses for genome-wide association study data is expected to become the norm, and our work outlines a critical approach for doing so.

4 November 2026 in Journal of Cataract & Refractive Surgery
Verified
Journal Article
Closed access
SASuleiman Adawi
Suleiman Adawi
ASAvinoam Shye-Shahar
Avinoam Shye-Shahar
TSTzahi Sela
Tzahi Sela
GMGur Munzer
Gur Munzer
AFAsaf Friehmann
Asaf Friehmann
Michael MimouniMichael Mimouni
Michael Mimouni
Purpose: To determine the incidence and independent predictors of incomplete corneal epithelialization at the one-week visit after photorefractive keratectomy (PRK), accounting for correlation between fellow eyes. Setting: A high-volume refractive-surgery network, Israel. Design: Retrospective registry-based cohort study. Methods: 37,982 eyes of 18,991 patients who underwent bilateral same-session PRK (January 2013-June 2024), examined on postoperative days 5-9. The outcome was modeled by generalized estimating equations (logistic; exchangeable correlation, robust standard errors) clustered on patient. Visit day and optical zone were also modeled categorically; surgeon was examined as a covariate and a clustering level. Results: Incomplete epithelialization occurred in 1,804 of 37,982 eyes (4.8%; 95% CI, 4.5-5.0). Rates were 17.2%, 5.5%, 4.3%, 4.1% and 3.3% on days 5 through 9. Day 5 carried almost five-fold the odds of day 7 (OR 4.78; 95% CI, 3.73-6.13) and day 6 remained elevated (OR 1.30; P=0.003); days 8-9 did not differ significantly from day 7. No surgical parameter was consistently associated with the outcome. Preoperative spherical equivalent, null in the primary model, was associated once surgeon was accounted for (OR 0.93 per +1 D; P=0.019). An affected eye predicted an affected fellow eye in 73.3% of affected eyes, against 1.33% of healed eyes. Conclusions: At one week, incomplete epithelialization is uncommon, is concentrated at day 5, and resolves gradually to a stable baseline by day 7, consistent with assessment timing rather than a distinct entity, and supporting a day-7 review default. It is predominantly patient-level, and no surgical parameter was consistently associated with it.